Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001017386-19-000081
Filing Date
2019-04-02
Accepted
2019-04-02 10:07:04
Documents
35
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT mctc_2019feb28-10q.htm 10-Q 144951
2 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 exhibit_31-1.htm EX-31.1 12504
3 CERTIFICATION PURSUANT TO 18 U.S.C. 1350 exhibit_32-1.htm EX-32.1 4985
  Complete submission text file 0001017386-19-000081.txt   962517

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE mctc-20190228.xml EX-101.INS 91412
5 XBRL SCHEMA FILE mctc-20190228.xsd EX-101.SCH 13830
6 XBRL CALCULATION FILE mctc-20190228_cal.xml EX-101.CAL 27656
7 XBRL DEFINITION FILE mctc-20190228_def.xml EX-101.DEF 23451
8 XBRL LABEL FILE mctc-20190228_lab.xml EX-101.LAB 110307
9 XBRL PRESENTATION FILE mctc-20190228_pre.xml EX-101.PRE 82867
Mailing Address 1919 NW 19TH STREET SUITE 302 FT. LAUDERDALE FL 33311
Business Address 1919 NW 19TH STREET SUITE 302 FT. LAUDERDALE FL 33311 (954) 551-7701
MCTC Holdings, Inc. (Filer) CIK: 0001413488 (see all company filings)

EIN.: 831754057 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 333-146404 | Film No.: 19723119
SIC: 2836 Biological Products, (No Diagnostic Substances)